By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).

Contact Information

Website: www.qiagen.com
Email: sarah.fakih@qiagen.com
Main Phone: +31 773556600
Address: Hulsterweg 82
City / Town: Venlo
Country: NL
Postal Code: 5912 PL

Issuer Information

Exchange: NYE
CEO: Thierry Bernard
Employees: 5610
NAICS: Research and Development in the Social Sciences and Humanities(541720)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A